Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
CONMED Corporation stock logo
CNMD
CONMED
$54.71
+2.5%
$52.65
$46.00
$78.19
$1.65B1.17582,645 shs552,572 shs
National Vision Holdings, Inc. stock logo
EYE
National Vision
$22.64
-6.3%
$23.52
$9.56
$25.67
$1.91B1.272.14 million shs2.55 million shs
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
$92.28
-2.1%
$83.35
$71.42
$109.58
$2.13B0.79146,164 shs149,596 shs
ZimVie Inc. stock logo
ZIMV
ZimVie
$18.81
-0.2%
$12.07
$8.15
$18.98
$531.59M2.21.23 million shs213,224 shs
7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
CONMED Corporation stock logo
CNMD
CONMED
+2.56%+4.71%+3.42%-4.22%-17.80%
National Vision Holdings, Inc. stock logo
EYE
National Vision
-6.33%-6.48%-10.34%+31.86%+107.14%
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
-2.10%+13.87%+9.14%+15.06%+14.92%
ZimVie Inc. stock logo
ZIMV
ZimVie
-0.21%+0.27%+98.21%+114.73%+10.39%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
CONMED Corporation stock logo
CNMD
CONMED
3.9783 of 5 stars
1.13.02.54.32.60.03.1
National Vision Holdings, Inc. stock logo
EYE
National Vision
3.0149 of 5 stars
2.32.00.03.33.90.80.0
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
2.3776 of 5 stars
1.33.03.30.02.72.51.3
ZimVie Inc. stock logo
ZIMV
ZimVie
0.9114 of 5 stars
1.05.00.00.01.91.70.0
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
CONMED Corporation stock logo
CNMD
CONMED
2.20
Hold$59.809.30% Upside
National Vision Holdings, Inc. stock logo
EYE
National Vision
2.60
Moderate Buy$24.739.22% Upside
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
2.50
Moderate Buy$98.006.20% Upside
ZimVie Inc. stock logo
ZIMV
ZimVie
2.00
Hold$17.75-5.64% Downside

Current Analyst Ratings Breakdown

Latest ZIMV, EYE, LMAT, and CNMD Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/7/2025
National Vision Holdings, Inc. stock logo
EYE
National Vision
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$17.00 ➝ $22.00
8/7/2025
National Vision Holdings, Inc. stock logo
EYE
National Vision
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$24.00 ➝ $27.00
8/7/2025
National Vision Holdings, Inc. stock logo
EYE
National Vision
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$30.00 ➝ $28.00
8/6/2025
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$92.00 ➝ $95.00
8/6/2025
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
Barrington Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeMarket Perform ➝ Outperform$95.00
7/31/2025
CONMED Corporation stock logo
CNMD
CONMED
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$80.00 ➝ $68.00
7/31/2025
ZimVie Inc. stock logo
ZIMV
ZimVie
B. Riley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Neutral$19.00
7/30/2025
National Vision Holdings, Inc. stock logo
EYE
National Vision
Roth Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$36.00
7/23/2025
National Vision Holdings, Inc. stock logo
EYE
National Vision
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$15.00 ➝ $24.00
7/22/2025
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
Barrington Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingMarket Perform ➝ Market Perform
7/22/2025
ZimVie Inc. stock logo
ZIMV
ZimVie
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeUnderweight ➝ Equal Weight$9.00 ➝ $19.00
(Data available from 8/9/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
CONMED Corporation stock logo
CNMD
CONMED
$1.31B1.30$6.88 per share7.95$32.40 per share1.69
National Vision Holdings, Inc. stock logo
EYE
National Vision
$1.82B0.98$1.53 per share14.77$10.76 per share2.10
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
$219.86M9.50$2.34 per share39.46$16.02 per share5.76
ZimVie Inc. stock logo
ZIMV
ZimVie
$449.75M1.18$1.85 per share10.15$14.64 per share1.28
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
CONMED Corporation stock logo
CNMD
CONMED
$132.42M$3.5315.5010.791.828.31%14.43%6.05%N/A
National Vision Holdings, Inc. stock logo
EYE
National Vision
-$28.50M-$0.33N/A83.852.91-0.75%3.56%1.49%N/A
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
$44.04M$2.0644.8042.532.4220.08%13.67%9.14%N/A
ZimVie Inc. stock logo
ZIMV
ZimVie
-$25.83M-$0.70N/AN/A-4.39%6.37%3.34%N/A

Latest ZIMV, EYE, LMAT, and CNMD Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/6/2025Q2 2025
National Vision Holdings, Inc. stock logo
EYE
National Vision
$0.12$0.18+$0.06$0.11$469.21 million$486.42 million
8/5/2025Q2 2025
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
$0.57$0.60+$0.03$0.60$62.48 million$63.15 million
7/30/2025Q2 2025
CONMED Corporation stock logo
CNMD
CONMED
$1.13$1.15+$0.02$0.69$338.42 million$342.35 million
7/30/2025Q2 2025
ZimVie Inc. stock logo
ZIMV
ZimVie
$0.2080$0.26+$0.0520-$0.14$112.60 million$116.66 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
CONMED Corporation stock logo
CNMD
CONMED
$0.801.46%N/A22.66%N/A
National Vision Holdings, Inc. stock logo
EYE
National Vision
N/AN/AN/AN/AN/A
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
$0.800.87%N/A38.83%14 Years
ZimVie Inc. stock logo
ZIMV
ZimVie
N/AN/AN/AN/AN/A

Latest ZIMV, EYE, LMAT, and CNMD Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
8/8/2025
CONMED Corporation stock logo
CNMD
CONMED
quarterly$0.201.5%9/15/202510/3/2025
7/30/2025
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
quarterly$0.200.9%8/21/20258/21/20259/4/2025
5/21/2025
CONMED Corporation stock logo
CNMD
CONMED
quarterly$0.201.34%6/13/20256/13/20257/3/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
CONMED Corporation stock logo
CNMD
CONMED
0.88
2.23
1.00
National Vision Holdings, Inc. stock logo
EYE
National Vision
0.30
0.52
0.35
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
0.46
13.96
13.83
ZimVie Inc. stock logo
ZIMV
ZimVie
0.56
2.37
1.60

Institutional Ownership

CompanyInstitutional Ownership
CONMED Corporation stock logo
CNMD
CONMED
N/A
National Vision Holdings, Inc. stock logo
EYE
National Vision
N/A
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
84.64%
ZimVie Inc. stock logo
ZIMV
ZimVie
95.63%

Insider Ownership

CompanyInsider Ownership
CONMED Corporation stock logo
CNMD
CONMED
3.10%
National Vision Holdings, Inc. stock logo
EYE
National Vision
2.70%
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
9.50%
ZimVie Inc. stock logo
ZIMV
ZimVie
3.01%
CompanyEmployeesShares OutstandingFree FloatOptionable
CONMED Corporation stock logo
CNMD
CONMED
3,90030.95 million30.00 millionOptionable
National Vision Holdings, Inc. stock logo
EYE
National Vision
13,41179.05 million76.92 millionOptionable
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
49022.64 million20.45 millionOptionable
ZimVie Inc. stock logo
ZIMV
ZimVie
1,77028.20 million27.35 millionOptionable

Recent News About These Companies

ZimVie (NASDAQ:ZIMV) Stock Rating Lowered by B. Riley
ZimVie Reports Second Quarter 2025 Financial Results
Insights into ZimVie's Upcoming Earnings
ZimVie to sell to investment firm for about $730M
BC-Most Active Stocks
...

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
CONMED stock logo

CONMED NYSE:CNMD

$54.71 +1.33 (+2.49%)
Closing price 08/8/2025 03:59 PM Eastern
Extended Trading
$54.76 +0.05 (+0.10%)
As of 08/8/2025 06:27 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as provides supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. It markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. The company also provides battery-powered and autoclavable bone power tool systems for use in orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries under Hall surgical brand name. In addition, it offers general surgery products, including clinical insufflation systems under AirSeal brand; smoke removal devices under Buffalo Filter brand; endomechanical products, such as tissue retrieval bags, trocars, suction irrigation devices, graspers, scissors, and dissectors used in minimally invasive surgeries; and electrosurgical solution comprising monopolar and bipolar generators, argon beam coagulation generators, handpieces, smoke management systems and other accessories. Further, the company provides endoscopic technologies, including therapeutic and diagnostic products for use in gastroenterology procedures, and products for the treatment of diseases of the dilatation, hemostasis, biliary, structure management, and infection prevention and patient monitoring, including ECG and EEG electrodes, and cardiac defibrillation pads. It markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida.

National Vision stock logo

National Vision NASDAQ:EYE

$22.64 -1.53 (-6.33%)
Closing price 08/8/2025 04:00 PM Eastern
Extended Trading
$22.84 +0.20 (+0.86%)
As of 08/8/2025 04:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

National Vision Holdings, Inc., through its subsidiaries, operates as an optical retailer in the United States. The company operates in two segments, Owned & Host and Legacy. It offers eyeglasses and contact lenses, and optical accessory products; provides eye exams through its America's Best, Eyeglass World, Vista Optical, Fred Meyer, and Vista Optical military, as well as Vision Center branded stores; and offers health maintenance organization and optometric services. National Vision Holdings, Inc. was founded in 1990 and is headquartered in Duluth, Georgia.

LeMaitre Vascular stock logo

LeMaitre Vascular NASDAQ:LMAT

$92.28 -1.98 (-2.10%)
Closing price 08/8/2025 04:00 PM Eastern
Extended Trading
$92.27 -0.01 (-0.01%)
As of 08/8/2025 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

LeMaitre Vascular, Inc. develops, manufactures, and markets medical devices and implants used in the field of vascular surgery worldwide. It offers human cadaver tissue cryopreservation services; angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude the blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature. The company also provides artegraft biologic graft, a bovine carotid artery used for dialysis access; XenoSure biologic patches, used for closure of vessels after surgical intervention; VascuCel and CardioCel biologic patches, used in vessel repair, heart repair and reconstruction, and neonatal repairs; cardiovascular patches; carotid shunts that temporarily shunt the blood to the brain during the removal of plaque in a carotid endarterectomy surgery; biosynthetic vascular graft indicated for lower extremity bypass and dialysis access; and vascular grafts used to bypass or replace diseased arteries. In addition, it offers radiopaque tape, a medical-grade tape applied to the skin that enables surgeons and interventionalists to cross-refer between the inside and the outside of a patient's body and allows them to locate tributaries or lesions beneath the skin. Further, the company provides valvulotomes, which cut or disrupt valves in the saphenous vein to function as an artery to carry blood past diseased arteries to the lower leg or the foot; and closure systems to attach vessels to one another with titanium clips instead of sutures. It markets its products through a direct sales force and distributors. The company was formerly known as Vascutech, Inc. and changed its name to LeMaitre Vascular, Inc. in April 2001. LeMaitre Vascular, Inc. was incorporated in 1983 and is headquartered in Burlington, Massachusetts.

ZimVie stock logo

ZimVie NASDAQ:ZIMV

$18.81 -0.04 (-0.21%)
Closing price 08/8/2025 04:00 PM Eastern
Extended Trading
$18.82 +0.01 (+0.03%)
As of 08/8/2025 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ZimVie Inc., together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment. The company offers dental implant systems, prosthetic and abutment products, surgical instrumentation, and kits; and patient-specific restorative solutions, such as abutments, bars, implant bridges, and hybrid restorations under the BellaTek brand name. It provides bone grafts, barrier membranes, and collagen wound care products; virtual treatment planning services, guided surgery solutions, CAD/CAM workflow systems, and intra-oral scanners; and Implant Concierge, a web-based treatment planning and surgery guide service. In addition, the company designs, manufactures, and distributes spinal fusion implants, instrumentation for various spinal procedures, biologics, and bone healing technologies. Further, it provides MIS solutions that deliver implant and instrumentation systems; and motion preservation solutions that offer non-fusion alternatives for cervical disc implant or growth modulation for anterior vertebral body tethering. The company sells its products to oral surgeons, dental specialists, general dentists, dental laboratories, and other dental organizations, including DSOs, as well as educational, medical, and governmental entities, hospitals, and surgery centers through direct sales representatives, agents, and distributors. ZimVie Inc. was incorporated in 2021 and is headquartered in Westminster, Colorado.